FXI 📈 iShares China Large-Cap - Overview
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642871846 • China Region
FXI: Chinese, Stocks, Companies, Hong Kong
The iShares China Large-Cap ETF, traded on the NYSE ARCA under the ticker symbol FXI, is designed to track the performance of the largest and most liquid Chinese companies listed on the Stock Exchange of Hong Kong, making it accessible to international investors. By investing at least 80% of its assets in the component securities of its underlying index, or in investments that have similar economic characteristics, the fund aims to replicate the performance of the Chinese large-cap market. This underlying index is specifically designed to measure the performance of the largest companies in the Chinese equity market that are available to international investors, providing a benchmark for the fund's performance.
As a non-diversified fund, the iShares China Large-Cap ETF may have a higher concentration of assets in a smaller number of securities, which can result in higher volatility compared to a diversified fund. However, this concentration can also allow the fund to more closely track the performance of the largest Chinese companies, potentially providing investors with exposure to the growth and development of the Chinese economy. With its domicile in the United States and an ISIN of US4642871846, the fund is classified as an exchange-traded fund (ETF) in the China Region category, offering investors a convenient and liquid way to gain exposure to the Chinese market.
The fund's investment strategy is designed to provide investors with a cost-effective and efficient way to gain exposure to the Chinese large-cap market, while also providing the benefits of trading on a major US exchange. As part of the iShares family of ETFs, the fund is supported by a robust infrastructure and a well-established brand, with more information available on the company's website at http://www.ishares.com. By tracking the performance of the largest Chinese companies listed on the Stock Exchange of Hong Kong, the iShares China Large-Cap ETF offers investors a unique opportunity to participate in the growth and development of the Chinese economy, while also providing the benefits of liquidity and transparency associated with trading on a major US exchange.
Additional Sources for FXI ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FXI ETF Overview
Market Cap in USD | 7,302m |
Category | China Region |
TER | 0.74% |
IPO / Inception | 2004-10-05 |
FXI ETF Ratings
Growth 5y | -23.6% |
Fundamental | - |
Dividend | 16.0% |
Rel. Strength Industry | 29.6 |
Analysts | - |
Fair Price Momentum | 29.40 USD |
Fair Price DCF | - |
FXI Dividends
Dividend Yield 12m | 0.27% |
Yield on Cost 5y | 0.22% |
Annual Growth 5y | -8.63% |
Payout Consistency | 93.8% |
FXI Growth Ratios
Growth Correlation 3m | -65.2% |
Growth Correlation 12m | 85.8% |
Growth Correlation 5y | -77.2% |
CAGR 5y | -4.37% |
CAGR/Mean DD 5y | -0.13 |
Sharpe Ratio 12m | 0.96 |
Alpha | 17.75 |
Beta | 0.60 |
Volatility | 29.32% |
Current Volume | 20218.1k |
Average Volume 20d | 42645.2k |
As of December 27, 2024, the stock is trading at USD 31.09 with a total of 20,218,100 shares traded.
Over the past week, the price has changed by +3.46%, over one month by +6.25%, over three months by +6.75% and over the past year by +36.33%.
Neither. Based on ValueRay Analyses, iShares China Large-Cap is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -23.56 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FXI as of December 2024 is 29.40. This means that FXI is currently overvalued and has a potential downside of -5.44%.
iShares China Large-Cap has no consensus analysts rating.
According to ValueRays Forecast Model, FXI iShares China Large-Cap will be worth about 32.3 in December 2025. The stock is currently trading at 31.09. This means that the stock has a potential upside of +3.83%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 32.3 | 3.8% |